Interferon-Free Hepatitis C Therapy

  title={Interferon-Free Hepatitis C Therapy},
  author={Dr Paul J. Pockros},
Two oral direct-acting antivirals (DAA) are now available for the treatment of chronic hepatitis C infection and several generations of DAA are in development. Expectations are that, at some time in the near future, hepatitis C will be ‘curable’ with an all-oral DAA regimen. This article reviews the current problems associated with interferon-based hepatitis C treatments that are combined with DAAs, including adverse events and complications of therapy, contraindications, drug-drug interactions… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS


Publications referenced by this paper.
Showing 1-10 of 25 references

Alisporivir plus ribavirin is highly effective as interferon-free or interferonadd-on regimen in previously untreated HCV-GT2 or GT3 patients: SVR12 results from VITAL-1 phase 2b study

  • JM Pawlotsky, SK Sarin, G Foster
  • [abstract no. LB 11]. 47th Annual Meeting of the…
  • 2012
Highly Influential
7 Excerpts

Highlights of prescribing information: VICTRELIS (boceprevir) capsules for oral use

  • Merck Sharp, Dohme Corp
  • Whitehouse Station (NJ): Merck Sharp & Dohme Corp…
  • 2012
Highly Influential
7 Excerpts

Interferon-free treatment with a combination of mericitabine and danoprevir/R with or without ribavirin in treatment-naı̈ve HCV genotype 1-infected patients [abstract

  • EJ Gane, P Pockros, S Zeuzem
  • J Hepatology 2012;
  • 2012
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…